News
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
H ealth officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported ...
10h
News-Medical.Net on MSNTirzepatide tops the charts for blood sugar and weight loss in type 2 diabetesA large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
4d
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...
5d
ScienceAlert on MSNNew Weight-Loss Drugs Under Scrutiny Amid Pancreas ConcernsTo date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...
Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 ...
5d
News Medical on MSNThe Most Effective Diabetes Drugs Don’t Reach Enough Patients YetA study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results